US Bancorp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-32,000
| Closed | -$28.4K | – | 4220 |
|
|
2022
Q4 | $28.4K | Sell |
32,000
-9,880
| -24% | -$8.75K | ﹤0.01% | 2806 |
|
|
2022
Q3 | $66K | Buy |
41,880
+4,846
| +13% | +$7.64K | ﹤0.01% | 2392 |
|
|
2022
Q2 | $74K | Sell |
37,034
-4,776
| -11% | -$9.54K | ﹤0.01% | 2376 |
|
|
2022
Q1 | $97K | Buy |
41,810
+9,941
| +31% | +$23.1K | ﹤0.01% | 2291 |
|
|
2021
Q4 | $149K | Buy |
31,869
+6,269
| +24% | +$29.3K | ﹤0.01% | 2096 |
|
|
2021
Q3 | $195K | Sell |
25,600
-240
| -0.9% | -$1.83K | ﹤0.01% | 1977 |
|
|
2021
Q2 | $251K | Buy |
25,840
+2,350
| +10% | +$22.8K | ﹤0.01% | 1873 |
|
|
2021
Q1 | $195K | Buy |
23,490
+5,863
| +33% | +$48.7K | ﹤0.01% | 1925 |
|
|
2020
Q4 | $120K | Buy |
17,627
+581
| +3% | +$3.96K | ﹤0.01% | 2123 |
|
|
2020
Q3 | $190K | Buy |
17,046
+5,392
| +46% | +$60.1K | ﹤0.01% | 1785 |
|
|
2020
Q2 | $74K | Buy |
+11,654
| New | +$74K | ﹤0.01% | 2218 |
|